Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CYBB/NOX2 Antibody - BSA Free, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 2 publications
Supplier: Novus Biologicals NBP241291
Description
CYBB/NOX2 Polyclonal specifically detects CYBB/NOX2 in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
CYBB/NOX2 | |
Polyclonal | |
Unconjugated | |
PBS with 0.02% Sodium Azide | |
CYBB | |
Antibody was raised against a 15 amino acid peptide near the amino terminus of human NOX2. The immunogen is located within amino acids 140 - 190 of NOX2. Amino Acid Squence: NFARKRIKNPEGGLY | |
Affinity Purified | |
RUO | |
1536 | |
Human, Mouse, Rat | |
IgG |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
1 mg/mL | |
Western Blot 1-2 ug/ml, ELISA, Immunohistochemistry 2 ug/ml, Immunocytochemistry/Immunofluorescence 20 ug/ml, Immunohistochemistry-Paraffin 2 ug/ml | |
CGD, CGD91-phox, Cytochrome b(558) subunit beta, cytochrome b-245 heavy chain, cytochrome b-245, beta polypeptide, Cytochrome b558 subunit beta, EC 1.6.3, GP91-1, GP91PHOX, GP91-PHOX, Heme-binding membrane glycoprotein gp91phox, NADPH oxidase 2, Neutrophil cytochrome b 91 kDa polypeptide, NOX2chronic granulomatous disease, p22 phagocyte B-cytochrome, p91-PHOX, Superoxide-generating NADPH oxidase heavy chain subunit | |
Rabbit | |
58 kDa | |
0.1 mg | |
Primary | |
At least two isoforms are known to exist; this antibody will detect both isoforms. NOX2 is predicted to not cross-react with other NOX proteins. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction